Neurovascular astrocyte dysfunction in VCID
VCID 中的神经血管星形胶质细胞功能障碍
基本信息
- 批准号:9306465
- 负责人:
- 金额:$ 37.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAstrocytesAutopsyBasal laminaBiochemicalBlood flowBrainCerebral Amyloid AngiopathyCerebrovascular CirculationCerebrovascular DisordersCerebrovascular systemCharacteristicsComorbidityDataDementiaDiagnosisDystroglycanElectrophysiology (science)EnvironmentEnzymesExtracellular MatrixFamilyFunctional disorderGene ExpressionGlial Fibrillary Acidic ProteinHistologicHomeostasisHumanHyperhomocysteinemiaImpaired cognitionImpairmentInhibition of Matrix Metalloproteinases PathwayInterleukin-1 betaKnockout MiceMMP9 geneMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMeasuresMediator of activation proteinMethodsModelingMolecularMorphologyMusNeurogliaNeuronal DysfunctionNeuronsPathologicPathologic ProcessesPathologyPatientsPharmacologyPilot ProjectsPotassiumPrevalenceProteinsResearch ProposalsRoleTNF geneTestingTimeTissuesaquaporin 4behavioral outcomecerebrovascularfoothuman tissuelarge-conductance calcium-activated potassium channelsmouse modelneuroinflammationneurovascularprotein expressionvascular cognitive impairment and dementia
项目摘要
Abstract
Vascular cognitive impairment and dementia (VCID) is the second leading cause of dementia behind
Alzheimer's disease (AD). In addition, VCID is a frequent co-morbidity with AD, complicating the diagnosis and
treatment of AD for a significant proportion of AD patients. Despite its prevalence, VCID remains relatively
understudied compared to AD, and little is known about the molecular mechanisms underlying the cognitive
dysfunction resulting from cerebrovascular disease. In part, this is due to the multiple pathological processes
disrupting neurovascular networks that can result in VaD.
We have previously shown that astrocytic end-feet are significantly impacted in the presence of
cerebral amyloid angiopathy (CAA), with decreased contact of astrocytic end-feet with the vasculature. Further,
these morphological changes in the astrocyte were associated with decreased expression of aquaporin 4,
Kir4.1 and BK channels at the astrocytic end-feet. We have developed a model of VCID through the induction
of hyperhomocysteinemia (HHcy). We have shown that this model in wildtype mice is associated with multiple
microhemorrhages, reduced blood flow, neuroinflammation and cognitive impairment. We now have intriguing
preliminary data that indicates these same pathological changes in the astrocytes that we observed with CAA
also occur in our HHcy model of VCID.
In this research proposal we will use the HHcy model of VCID. We will test the hypothesis that
astrocyte end-foot disruption contributes to neuronal dysfunction and that the activation of MMP9 in
the HHcy model is critical to the disruption of the astrocytic end-feet. We have developed 3 specific aims.
Aim 1. Test the hypothesis that astrocytic end-foot disruption leads to neuronal dysfunction and impaired
potassium homeostasis.
Aim 2. Test the hypothesis that MMP9 is an essential mediator of astrocyte end-foot detachment from the
cerebrovasculature with VCID.
Aim 3. Test the hypothesis that astrocytic end-foot disruption is a common pathological characteristic of
cerebrovascular pathologies of VCID.
摘要
血管性认知障碍和痴呆(VCID)是痴呆的第二大原因,
阿尔茨海默病(AD)。此外,VCID是AD的常见并发症,使诊断复杂化,
治疗AD患者的显著比例。尽管VCID普遍存在,但相对而言,
与AD相比,研究不足,并且对认知障碍的分子机制知之甚少。
脑血管疾病导致的机能障碍。在某种程度上,这是由于多种病理过程
破坏神经血管网络导致血管性痴呆
我们以前已经证明,星形胶质细胞终足在存在以下情况时受到显著影响:
脑淀粉样血管病(CAA),星形胶质细胞终足与血管系统的接触减少。此外,本发明还
星形胶质细胞中的这些形态学变化与水通道蛋白4的表达降低有关,
星形胶质细胞末端足的Kir4.1和BK通道。我们通过归纳建立了一个VCID模型,
高同型半胱氨酸血症(HHcy)我们已经证明,野生型小鼠的这种模型与多种
微血管扩张、血流量减少、神经炎症和认知障碍。我们现在有了有趣的
初步数据表明,我们在CAA中观察到的星形胶质细胞中存在相同的病理变化,
也发生在我们的VCID的HHcy模型中。
在本研究中,我们将使用VCID的HHcy模型。我们将检验这个假设,
星形胶质细胞末端破坏导致神经元功能障碍,
HHcy模型对于星形胶质细胞终足的破坏是至关重要的。我们制定了三个具体目标。
目标1。验证星形胶质细胞终足破坏导致神经元功能障碍和受损的假设。
钾稳态
目标2.验证MMP 9是星形胶质细胞终足脱离的重要介质这一假设。
VCID的血管。
目标3.检验星形胶质细胞终足破坏是脑胶质细胞瘤的常见病理特征这一假设。
VCID的脑血管病变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donna M Wilcock其他文献
Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
- DOI:
10.1186/1742-2094-1-24 - 发表时间:
2004-01-01 - 期刊:
- 影响因子:10.100
- 作者:
Donna M Wilcock;Amyn Rojiani;Arnon Rosenthal;Sangeetha Subbarao;Melissa J Freeman;Marcia N Gordon;Dave Morgan - 通讯作者:
Dave Morgan
Donna M Wilcock的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donna M Wilcock', 18)}}的其他基金
Elucidating the role of placental growth factor in diffuse white matter disease
阐明胎盘生长因子在弥漫性白质疾病中的作用
- 批准号:
10851244 - 财政年份:2023
- 资助金额:
$ 37.59万 - 项目类别:
Establishing the role of MMP9 in amyloid-immunotherapy-induced ARIA
确定 MMP9 在淀粉样蛋白免疫疗法诱导的 ARIA 中的作用
- 批准号:
10607620 - 财政年份:2022
- 资助金额:
$ 37.59万 - 项目类别:
Core F: University of Kentucky Alzheimer's Disease Core Center
核心F:肯塔基大学阿尔茨海默病核心中心
- 批准号:
10261967 - 财政年份:2021
- 资助金额:
$ 37.59万 - 项目类别:
Core F: University of Kentucky Alzheimer's Disease Core Center
核心F:肯塔基大学阿尔茨海默病核心中心
- 批准号:
10459471 - 财政年份:2021
- 资助金额:
$ 37.59万 - 项目类别:
Core F: University of Kentucky Alzheimer's Disease Core Center
核心F:肯塔基大学阿尔茨海默病核心中心
- 批准号:
10662361 - 财政年份:2021
- 资助金额:
$ 37.59万 - 项目类别:
Elucidating the role of placental growth factor in diffuse white matter disease
阐明胎盘生长因子在弥漫性白质疾病中的作用
- 批准号:
10133181 - 财政年份:2020
- 资助金额:
$ 37.59万 - 项目类别:
Elucidating the role of placental growth factor in diffuse white matter disease
阐明胎盘生长因子在弥漫性白质疾病中的作用
- 批准号:
10379950 - 财政年份:2020
- 资助金额:
$ 37.59万 - 项目类别:
Elucidating the role of placental growth factor in diffuse white matter disease
阐明胎盘生长因子在弥漫性白质疾病中的作用
- 批准号:
10597648 - 财政年份:2020
- 资助金额:
$ 37.59万 - 项目类别:
Therapeutic targeting of TREM2 for Alzheimer's disease
TREM2 治疗阿尔茨海默病的靶向治疗
- 批准号:
9423846 - 财政年份:2018
- 资助金额:
$ 37.59万 - 项目类别:
Neurovascular astrocyte dysfunction in VCID
VCID 中的神经血管星形胶质细胞功能障碍
- 批准号:
10183340 - 财政年份:2017
- 资助金额:
$ 37.59万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 37.59万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 37.59万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 37.59万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 37.59万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 37.59万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 37.59万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 37.59万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 37.59万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 37.59万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 37.59万 - 项目类别:














{{item.name}}会员




